Evidence map›Paper›PMID 32377869›Full record

ArticleWiener klinische Wochenschrift2021

HbA1c level decreases in iron deficiency anemia.

Seher Çetinkaya Altuntaş, Mehtap Evran, Emel Gürkan, Murat Sert, Tamer Tetiker

Abstract read
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Effect of iron deficiency anaemia over glycated hemoglobin in non-diabetic women.International journal of biochemistry and molecular biology · 2022
    Article
  12. Article
  13. Article
  14. HbA1c AND E-HEALTH: YOUTUBE MIGHT BE GOOD FOR YOU, IF YOU USE IT WISELY.Acta endocrinologica (Bucharest, Romania : 2005)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Seher Çetinkaya AltuntaşFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology, Recep Tayyip Erdoğan University, 053100, Rize, Turkey. drsehercetinkaya@hotmail.com.
Mehtap EvranFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology, Cukurova University, Adana, Turkey.
Emel GürkanCukurova University Medical Faculty, Department of Internal Medicine, Division of Hematology, Adana, Turkey.
Murat SertFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology, Cukurova University, Adana, Turkey.
Tamer TetikerFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology, Cukurova University, Adana, Turkey.
Cukurova University · TRRecep Tayyip Erdoğan University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemoglobin A1c (HbA1c) is the major form of glycosylated hemoglobin. There are conflicting data on changes in HbA1c levels in patients with iron deficiency anemia (IDA). The present study aimed to investigate the effects of HbA1c levels in the presence of IDA, the effects of iron treatment on HbA1c levels, as well as the relationship between the severity of anemia and HbA1c levels in patients without diabetes. DESIGN AND

methodsA total of 263 patients without diabetes mellitus (DM) who were admitted to Cukurova University, Faculty of Medicine, Department of Endocrinology and Hematology or who were followed up in this clinic and diagnosed as having IDA were included in the study. A total of 131 patients had IDA. The control group comprised 132 age-matched and sex-matched healthy individuals.

resultsThe mean HbA1c level was significantly lower in the group with IDA (5.4%) than in the healthy control group (5.9%; p < 0.05). When the patients were divided into three groups according to the severity of anemia through Hb levels, HbA1c levels were observed to decrease as the severity of the anemia increased (5.5%, 5.4%, and 5%, respectively; p > 0.05). The HbA1c levels of the patients with IDA were higher after iron therapy (from 5.4 ± 0.5 to 5.5 ± 0.3; p = 0.057). The mean hemoglobin (Hb), hematocrit (Hct), mean cell volume (MCV), mean corpusculer hemoglobin (MCH), and ferritin values also increased after iron therapy (p < 0.05).

conclusionThe study results showed that IDA was associated with low HbA1c levels, and increased after iron therapy. Based on the study findings, it is necessary to consider the possible effects of IDA on HbA1c levels.

Indexed as

AnemiaAnemia, Iron-DeficiencyDiabetes MellitusGlycated HemoglobinHumansIronGlycated HemoglobinIronAnemiaDiabetes mellitusHemoglobin A1cIron deficiency anemiaIron therapy

Identifiers

PMID32377869
OpenAlexW3022985689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.